section name header

Y-Site Injection Compatibility (1:1 Mixture)

Sulbactam sodium and durlobactam sodium

(Mfr: ENT)(Conc: 15 mg/mLa,b)

I

Ciprofloxacin

(Mfr: BA)(Conc: 2 mg/mLi)

Remarks:

Increase in measured turbidity and crystal formation in 4 hr at 20 to 22°C

Ref:

3983